Efficacy of izokibep, a novel interleukin-17A inhibitor, in moderate to severe hidradenitis suppurativa: Week 32 results from a randomized, double-blind, placebo-controlled, multicenter, phase 3 study

izokibep (ABY-035) - Affibody

https://eposters.aad.org/abstracts/71352

Kim A Papp; Falk G Bechara; Martina L Porter; Seth B Forman; Howard Sofen; Jacek C Szepietowski; Benjamin D Ehst; Antonio Martorell; Shephard Mpofu; Fredrik Y Frejd; Alexa B Kimball

Mar 3, 2026